MIM
ETON icon

MetLife Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

MetLife Investment Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$383K Hold
15,537
– – ﹤0.01% 1882
2025
Q4 		$263K Hold
15,537
– – ﹤0.01% 2144
2025
Q3 		$338K Hold
15,537
– – ﹤0.01% 2015
2025
Q2 		$221K Buy
+15,537
New +$246K ﹤0.01% 2138

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

MetLife Investment Management's ETON Position: Q1 2026 in Review

MetLife Investment Management held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 15,537 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1882.

MetLife Investment Management first reported a position in ETON in Q2 2025 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • MetLife Investment Management held 15,537 shares of Eton Pharmaceutcials worth $383K as of Q1 2026.
  • MetLife Investment Management left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1882 holding.
  • MetLife Investment Management first reported a position in Eton Pharmaceutcials in Q2 2025 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.